Abata Therapeutics
Company Details
Status: Private
Employees: 11-50
Location:
Cambridge, Massachusetts, United States
Type:
sample
Technology:
sample
sample
sample
sample
About: Abata Therapeutics - We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to our lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). We bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers.
We are bold in our mission and purpose and aim for nothing less than a transformative impact on people’s lives.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Abata Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.